The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| STE | +8.59% | +41.22% | +7.15% | +15,957% |
| S&P | +18.37% | +110.18% | +16.02% | +1,548% |
STERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Mentor, OH.
The medical equipment company closed its fiscal year with a strong quarter.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.39B | 8.7% |
| Gross Profit | $627.80M | 9.6% |
| Gross Margin | 45.13% | 0.4% |
| Market Cap | $23.63B | 8.9% |
| Market Cap / Employee | $1.33M | 0.0% |
| Employees | 17.8K | -2.2% |
| Net Income | $178.00M | 27.2% |
| EBITDA | $368.10M | 3.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $279.70M | 41.0% |
| Accounts Receivable | $947.10M | 6.1% |
| Inventory | 641.2 | -8.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.03B | -14.4% |
| Short Term Debt | $35.30M | -67.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 6.31% | 1.1% |
| Return On Invested Capital | 5.68% | -0.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $326.40M | 66.8% |
| Operating Free Cash Flow | $420.00M | 38.3% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 55.40 | 43.59 | 36.19 | 36.42 | -33.21% |
| Price to Book | 3.77 | 3.08 | 3.47 | 3.58 | 3.81% |
| Price to Sales | 4.44 | 3.77 | 4.10 | 4.26 | 6.16% |
| Price to Tangible Book Value | 96.29 | 46.28 | 49.61 | 36.14 | -81.32% |
| Price to Free Cash Flow TTM | 51.23 | 38.10 | 40.27 | 34.81 | -38.01% |
| Enterprise Value to EBITDA | 77.24 | 59.80 | 58.66 | 69.37 | 2.00% |
| Free Cash Flow Yield | 2.0% | 2.6% | 2.5% | 2.9% | 61.32% |
| Return on Equity | 9.1% | 9.6% | 9.5% | 9.7% | 11.03% |
| Total Debt | $2.40B | $2.32B | $2.20B | $2.07B | -16.74% |
STE earnings call for the period ending September 30, 2021.
STE earnings call for the period ending June 30, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
